Dr. Reddy’s Q4 Profit Jumps 22% | Big Growth in NRT Business! #drreddysharenewstoday

Key Financial Highlights (Q4FY25 vs Q4FY24):
• Net Profit: ₹1,594 crore (↑ 22% YoY)
Above Street estimate of ₹1,491 crore
• Revenue: ₹8,506 crore (↑ 20% YoY)
Last year: ₹7,083 crore
• EBITDA: ₹2,975 crore (↑ 59% YoY)
• EBITDA Margin: 29.1% (↑ 510 bps YoY)
• Dividend: ₹8 per share
Record date: July 10, 2025

Segment-wise Revenue:
• Global Generics: ₹7,536 crore (↑ 23% YoY)
~90% of total revenue
• Pharmaceutical Services & Active Ingredients (PSAI): ₹1,167 crore (flat YoY)
• Consumer Healthcare (NRT): ₹597 crore
Excluding NRT, core revenue growth was 12% YoY

Full-Year FY25 Performance:
• Revenue: ₹32,553 crore (↑ 17% YoY)
• Net Profit: ₹5,654 crore (↑ 2% YoY)

Management Commentary:
• Growth driven by:
• Successful product launches
• Strong US product performance
• Integration of Nicotine Replacement Therapy business
• Focus remains on core portfolio expansion, operational excellence, and inorganic growth.
1.What is Nicotine Replacement Therapy (NRT)?
2.How did Dr. Reddy’s perform in Q4 FY25?
3.Why did Dr. Reddy’s profit rise this quarter?
4.What is the significance of the ₹8 dividend?
5.Should you invest in pharma stocks now?

#DrReddys #Q4Results #StockMarketIndia #PharmaStocks #EarningsSeason #InvestSmart #NRTBusiness #DividendStocks #FinancialNews #HinglishFinance #IndianPharma #ProfitJump #StockMarketUpdate #WealthCreation #BusinessNews
SUBSCRIBE : https://www.youtube.com/@moneyroots

Disclaimer:
The content on this YouTube channel is for informational and educational purposes only and should not be considered as financial, investment, or trading advice. We are not SEBI-registered advisors, and all opinions expressed are personal.
Investing and trading in the stock market involve risk, and past performance does not guarantee future results. Always conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.
This channel does not guarantee the accuracy, completeness, or reliability of any information provided. We are not responsible for any financial losses or decisions made based on the content shared.
This channel may include affiliate links, sponsorships, or partnerships, and we may earn commissions from qualifying purchases or sign-ups.
By watching this channel, you acknowledge and agree to these terms.

Видео Dr. Reddy’s Q4 Profit Jumps 22% | Big Growth in NRT Business! #drreddysharenewstoday канала Money Roots